Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease (Q34318007)

1 August 2017

1 reference

title

Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease (English)

1 reference

1 August 2017

1 reference

Hornykiewicz O

1

1 reference

1 August 2017

1 July 2001

1 reference

Journal of Chemical Neuroanatomy

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

1-2

1 reference

1 August 2017

3-12

1 reference

Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Occurrence and distribution of dopamine in brain and other tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Dopaminergic neurons intrinsic to the primate striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Brain Norepinephrine and Dopamine in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Cognitive function in Parkinson's disease: From description to theory

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Morphological and Functional Aspects of Central Monoamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Neurotransmitters and neuromodulators in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Functional effects of striatal dysfunction in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Biochemical aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Cognitive deficits in the early stages of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Regional distribution of monoamines and their metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Differential dopaminergic innervation of the two pallidal segments in the squirrel monkey (Saimiri sciureus).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Human brain neurochemistry — Some postmortem problems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Distribution of catechol compounds in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Post-mortem stability of dopamine, glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Functional and pathophysiological models of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Monoamines and monoamine metabolites in brains from demented schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2801%2900100-4

7 January 2021

10.1016/S0891-0618(01)00100-4

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11470551